Skip to main content
. 2021 Apr 13;66:103332. doi: 10.1016/j.ebiom.2021.103332

Fig. 6.

Fig. 6

Effect of FSG67 on treatment with gemcitabine, oxaliplatin and 5-FU. PDAC013T, PDAC017T, PDAC053T and PDAC056T primary cells were treated with increasing concentrations of gemcitabine (a), oxaliplatin (b) and 5-FU (c) in the presence (green) or absence (red) of FSG67. The GR_AOC, represented as boxplots, in the presence or absence of the FSG67 was analyzed.(For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)